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Abstract 
 
Background: To study the histomorphological effects 
of Mifepristone treatment on rat uterus. 
Methods: In this experimental study, sixty adult female 
rats were divided randomly into two groups, comprising of 
30 animals in each group. In group A one ml of normal 
saline was given orally daily for three months while in 
group B mifepristone was given orally in a dose of 1 mg/kg 
body weight daily for three months. All the animals were 
sacrificed next day after the last oral dose. Two ml blood 
was taken directly from the heart for measurement of 
estrogen and progesterone levels. About ½ cm piece of 
tissue was taken from the middle of the right uterine horn. 
Sections were cut and immunohistochemical staining 
procedure was done for demonstration of progesterone 
and estrogen receptors 
Results: In the experimental group the number of 
progesterone and estrogen receptors in the uterine 
myometrium of the experimental group were decreased 
and found statistically significant. Significantly lower 
level of progesterone while higher levels of estrogen level 
were noted in the experimental group as compared to 
control group. In the experimental group thickness of the 
myometrium was reduced 
Conclusion: Long term mifepristone (Anti-
progesterogen)  administration suppresses the endometrial 
proliferation. It decreases the number of progesterone  and 
estrogen receptors. It lowers the serum  levels of 
progesterone, while estrogen levels elevates it. 
Keywords: Mifepristone, estrogen, progesterone, 
myometrium. 
 
Introduction 
Estrogen and Progesterone responsive tissues 
are initially determined by the tissue distribution of 
receptor proteins whose restricted spatiotemporal 
expression identifies tissues targeted for hormonal 
response. However, tissues that express receptors for 
estrogen and progesterone exhibit physiologically 
diverse responses to the same steroidal ligand. 
Functional diversity arises from the existence of two 
structurally related but nonidentical receptors of each 
hormone and by the ability of a single receptor 
subtype elicits diverse transcriptional response to a 
specific ligand. Steroid receptors including those for 
estrogen and progesterone have a modular protein 
structure consisting of distinct functional domains 
capable of binding steroidal ligand, dimerization of 
ligand receptors, interaction with hormone responsive 
DNA elements, and interaction with coregulator 
proteins required for bridging receptors to the 
transcriptional apparatus. 2 
 Binding of estrogen and progestin agonists to 
their receptors induces conformational changes in 
receptor structure that promote interaction of 
coactivator proteins with distinct activation domains 
(AFs) located within both the amino and carboxy 
terminal regions of the receptor. Such coactivators 
promote chromatin remodeling and bridging the 
general transcription factors resulting in the formation 
of productive transcription initiation complexes at the 
receptor responsive promoter. 2 
Mifepristone acts at the receptor level, binding 
strongly to the progesterone and glucocorticoid 
receptors, and to a lesser extent to the androgen 
receptor. It is relatively five times greater than 
progesterone, three times greater than dexamethasone 
and four times less than testosterone, respectively. 
Mifepristone, like progesterone, enters target cells and 
reaches its receptors; however, it interacts differently 
from progesterone and may produce different 
conformational changes in the receptor. By occupying 
the progesterone receptor in the nucleus, progesterone 
modifies the receptor’s shape, enabling it to bind to 
chromatin, and this binding leads to gene transcription 
and protein synthesis. 3-5 
 
Material and Methods 
These laboratory based randomized controlled 
trials were conducted at the department of Anatomy, 
Army Medical College Rawalpindi from Jan 2007-
Journal of Rawalpindi Medical College (JRMC); 2012;16(1):55-58 
 
 56 
March 2007. Sixty healthy adult female Sprague 
Dawley rats weighing 200-300 g were procured from 
the National Institute of Health Sciences Islamabad. 
The animals were randomly divided into two groups 
of 30 each.Group A (Control) comprised thirty female 
rats and were given one ml of normal saline orally 
daily for three months.Group B (Experimental) 
comprised thirty female rats and were given the drug 
(Mifepristone) orally in a dose of 1 mg/kg body 
weight daily for three months.All the animals were 
sacrificed next day after the last oral dose. Two ml 
blood was taken directly from the heart for 
measurement of estrogen and progesterone levels. 
Uterine horns along with a portion of vagina was 
removed, trimmed and placed into 10% Formalin for 
24 hours About ½ cm piece of tissue was taken from 
the middle of the right uterine horn. It was passed 
through ascending series of alcohol from 70% to 100%, 
cleared in xylene, infiltrated and embedded in paraffin 
wax at 580C . Sections were stained with hematoxylin 
and eosin for light microscopic study 
Immunohistochemical staining procedure was done 
for demonstration of estrogen and progesterone 
receptors Microscopic observations: 
On microscopic examination thickness of the 
myometrium was taken by measuring the maximum 
thickness of the myometrium  between two points on 
uterine wall one on the side merging with the 
endometrium and other up to the inner limit of the 
serosa. On immuno histochemistry  number of mild, 
moderate, and marked brown stained progesterone 
and estrogen receptors in the myometrial cells were 
counted per cross section and their mean was 
calculated. 
 
Results 
Total sixty animals were included in the study, 
30 in each group. In control group the Middle layer 
(Myometrium) consisted of elongated spindle shaped 
cells with pointed ends. Nuclei were elongated and 
centrally located. These were smooth muscle cells, 
composed of interlacing bundles of long slender fibers 
arranged in ill defined layers of thick inner circular 
and outer longitudinal layers. The longitudinal muscle 
layer was closely applied to the circular layer with 
only a minimal amount of connective tissue having 
network of tubular structures lined with single layer of 
flattened cells representing the blood vessels(Fig 1). 
The considerable numbers of mitotic figures were 
observed in the muscle layers. The mean thickness of 
myometrium was355.3±16.1 µm. (Table I).  
Table 1: Number of Progesterone Receptors in 
Uterine Tissues 
Progesterone 
Receptors 
Control 
(n=30) 
Mean +SE 
Experimental 
(n=30) 
Mean +SE 
Statistical 
Significance  
(p-value) 
Myometrial 
cells 199.7 ± 17 10.6 ± 2.9 <0.001 
 
Table 2: Number of Estrogen Receptors in 
Uterine Tissue 
Estrogen 
Receptors 
Control 
(n=30) 
Mean + SE 
Experimental 
(n=30) 
Mean + SE 
Statistical 
Significance  
(p-value) 
Myometrial 
cells 184.0 ± 7.8 149 ± 23 >0.05 
 
Table 3: Comparison between Control and 
Experimental groups 
Parameters 
Control 
(n=30) 
Mean  SE 
Experimental 
(n=30) 
Mean  SE 
p value 
Thickness of 
myometrium  
(μm) 
355.316.1 148.669.6 p =0.001 
Progesterone 
  ng/ml 5.50.8 2.80.09 p =0.001 
Estrogen 
pg/ml 41.7.66 83.6. 1.2 p =0.001 
Values are expressed as mean  SD;NS = Insignificant;= Significant 
 
        Total number of Progesterone receptors (PR) in 
the myometrial cells of the uterus was 6101 (Mild 
stained 1621, moderate stained 3040 and marked 
stained 1440) (Table I). In the control group 
myometrial cells showed more number of marked 
staining PR  as compared to the mild and moderate 
stained PR. Mild, moderate and marked estrogen 
receptors were also counted in the myometrial cells. 
Total number of ER in the myometrial cells of the 
uterus was 5771 (Mild stained 1110, moderate stained 
2980 and marked stained 1681) (Table 2). 
In experimental group middle layer 
(myometrium) as compared with controls was 
decreased in thickness. Their spindle shaped cells were 
loosely arranged in ill defined layers of inner circular 
and outer longitudinal layers. The amount of 
connective tissue intervening between these layers was 
increased .Increased number of infiltration of 
granulocytes was observed. Eosinophils were more in 
number (Fig 2). The outer most layers were composed 
of loose connective tissue with large number of dilated 
vessels as it was in the control group.  The mean 
thickness of myometrium (148.6+9.6 µm) was less  
than that of control group. The difference was highly 
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significant statistically (p =0.001) when compared with 
the control group  (Table.3). 
 
 
Figure 1: Uterine horn of animal of control group showing 
connective tissue having network of tubular structures 
lined with single layer of flattened cells representing the 
blood vessels (arrows).  
 
Figure 2: Uterine horn of animal of control group showing 
stroma consisted of stromal cells (SC), network of collagen 
fibers (CF) stained with eosin, intermingled with 
amorphous ground substance  
 
 
Figure3: Uterine horn from animal of control group 
showing moderately stained PR with immunostaining in  
myometrium and mild stained PR with immunostaining in 
myometrium of animal  
      Total number of PR in the myometrial cells of the 
uterus was 318.(Mild stained 17, moderate stained 134 
and marked staining 167) (Fig 3). The number of 
progesterone receptors in myometrial cells of the 
uterus was reduced in the experimental group as 
compared with the control group (Fig 4).Myometrial 
cells showed more number of marked staining PR as 
compared to the mild and moderate staining PR. 
        The mild, moderate and marked estrogen 
receptors(ER) were also counted in the myometrial 
cells. Total number of ER in the myometrial cells of the 
uterus was 3806. (Mild stained 550, moderate stained 
1610 and marked stained 2220).The numbers of 
estrogen receptors in myometrial cells of the uterus 
were reduced in the experimental group as compared 
with the control group (Fig 5). Myometrial cells 
showed more number of marked staining ER as 
compared to the mild and moderate staining estrogen 
receptors 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  The mean serum estrogen level was (83.6±1.2 pg/ml), 
which was higher than that of the control group. The 
difference was found significant statistically when 
compared with the control group. The mean 
progesterone level was lower in experimental group 
than that of the control group  .The difference was 
found significant statistically when compared with 
control group (p =0.001) (Table 3) 
 
Discussion 
In the present study, the long term effects of 
Mifepristone treatment on rat myometrium were 
studied. The experimental group displayed the 
decrease in myometrial thickness, as compared to 
control group. Progesterone induced proliferative 
activity was profoundly reduced in experimental 
group. Mifepristone antagonizes the estrogen-induced 
proliferative response in uterine stromal and 
myometrial cells. Cell proliferation in the normal 
uterus corresponded with high serum levels of steroid 
hormones during the estrous cycle, and apoptosis 
occurred in the rat uterus in all cell types following 
sharp, cyclical declines in serum hormone levels.  The 
responsiveness of uterine mesenchymal cells decreases 
Fig 5: Progesterone receptors 
in myometrial cells of control 
and experimental group 
Fig 6: Estrogen receptors in 
myometrium of control 
and experimental groups 
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in both proliferative and apoptotic rates observed in 
myometrial and stromal cells of mifepristone treated 
animals. 6  
In the present study an attempt was made to 
determine whether the antiprogestin-induced anti-
estrogenic effects are reflected as change in the 
concentration or localization of endometrial ER and 
PR, as both of these receptor proteins are estrogen-
dependent.7Total number of PR in all the 
compartments of uterus was less as compared with the 
control group .The difference was statistically 
significant The number of progesterone receptors in 
the myometrial cells of the uterus was reduced in the 
experimental group as compared with the control 
group .Progesterone receptors (PR) mediate multiple 
aspects of female reproduction and are important 
targets for reagents that can modulate progesterone-
dependent events. Many such reagents have been 
developed, and they range from full PR antagonists 
(PAs) to compounds with mixed agonist/antagonist 
actions, currently known as selective progesterone 
receptor modulators (SPRMs).8 Myometrial cells 
showed more number of marked staining ER as 
compared to the mild and moderate staining estrogen 
receptors. This reflects significant change in the levels 
of endometrial ER in the treated groups as compared 
with the control group. Estrogen receptor is associated 
with shifts in uterine weight, proliferation and 
morphogenesis. Uterine ER levels were decreased by 
administration of progesterone to estrogen-treated 
rats. The progesterone-mediated decrease in ER 
protein has been shown in breast cancer cells to result 
from decreased cellular ER mRNA levels, likely to 
reflect decreased transcription of the ER gene, since 
the effect was seen rapidly without shortening of the 
ER mRNA half-life. 9 
The observation of the presence of ER at 
relatively high concentrations in smooth muscle cells 
of the myometrium of control group has led to the 
conclusion of a direct action of this steroid on smooth 
muscle cells. This suggests that populations of ER and 
PR in the endometrial stroma and myometrium are 
more stable than those in the epithelium. As the 
expression of estrogen receptors in our cases was 
associated with high plasma oestradiol concentrations, 
it is possible that the expression of these receptors can 
be oestradiol independent. Antiprogestrogen  
administration also inhibits estrogen-dependent 
endometrial cell proliferation and growth. 10 
 
Conclusion 
The antiproliferative effects of antiprogesterogen 
therapy formulates basis for their clinical utilization  
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